Mussel Adhesive Protein MAP Engineering Service

Mussel Adhesive Protein MAP is a natural polymer with superior performance as a Bio-adhesives/Medical adhesive, offering strong, water-resistant, non-toxic bonding for surgical glues and specialized coatings. The primary challenge is its availability: Low yield and extremely high cost from natural extraction; and recombinant expression is difficult due to repetitive, highly basic structure. This prevents its commercial adoption despite its functional superiority.

CD Biosynsis offers a dedicated recombinant expression and post-translational modification platform for MAP: Recombinant Expression: Engineer yeast P. pastoris for high-yield secretion of MAP sequences. Yeast is chosen for its efficiency in handling large, repetitive proteins. Crucially, we address the functional requirement through Post-translational Modification: Co-express Tyrosinase or Hydroxylase enzymes to catalyze the formation of DOPA a key adhesive group. The DOPA amino acid is the active component that mediates the strong wet adhesion, and its efficient incorporation is vital for functional protein production.

Pain Points

The transition to bio-manufactured MAP faces these critical challenges:

• Cost and Scarcity: Natural extraction of MAP requires hundreds of mussels to yield milligram quantities, leading to prohibitively high cost for commercial use.
• Difficult Recombinant Expression: The MAPgene sequence is highly repetitive and contains a high content of basic amino acids, making its stable expression and translation in conventional hosts like E. colichallenging.
• Lack of Functional Modification: The final functional adhesive activity of MAPrequires the conversion of tyrosine residues to DOPA dihydroxyphenylalanine, a post-translational modification PTMthat most conventional hosts cannot perform.
• Low Solubility and Secretion: The large, repetitive, and often highly charged recombinant MAPprotein frequently exhibits low solubility or poor secretion efficiency in microbial hosts.

A successful platform must achieve high-yield expression and ensure the crucial DOPAfunctional modification is performed.

Solutions

CD Biosynsis utilizes advanced synthetic biology and enzyme co-expression to optimize functional MAPproduction:

High-Yield Yeast Expression

           

We engineer Pichiapastoris, a host known for high protein expression and secretion, for the stable production and secretion of the synthetic MAP gene sequences.

Functional DOPA Modification

We implement co-expression of Tyrosinaseor Hydroxylaseenzymes to catalyze the in-vivo conversion of tyrosine residues to the functional DOPA groups, ensuring the protein's adhesive activity.

Gene Sequence Optimization

The MAPsequence is codon-optimized to ensure efficient translation in the Pichiahost, overcoming the translational difficulties posed by the highly repetitive and basic nature of the native gene.

Enhanced Secretion and Purification

We optimize the secretion leader sequence and incorporate purification tags for efficient release into the medium and subsequent simplified, high-purity recovery of the DOPA-functionalized MAP.

This combined approach ensures the production of large quantities of high-quality, functionally active MusselAdhesiveProtein.

Advantages

Our MAPengineering service is dedicated to pursuing the following production goals:

Low-Cost and Scalable Production Icon

Recombinant expression in yeast replaces expensive, low-yield natural extraction with a high-capacity bioreactor process.

Functionally Active DOPA Content Icon

Co-expression of Tyrosinaseensures the crucial DOPAmodification is performed for superior wet adhesion performance.

High Yield and Titer Icon

Optimized Pichiahost and expression cassette lead to significantly higher MAPyield than E. colior native extraction.

Non-Toxic and Biocompatible Icon

The final product is a natural protein that is highly biocompatible and suitable for medical and surgical applications.

High Purity for Medical Use Icon

The secretion-based system simplifies purification, allowing for high-purity isolation required for clinical use.

We deliver a high-quality, functionally active MAPready for commercial application in bio-adhesives and regenerative medicine.

Process

Our MAPengineering service follows a rigorous, multi-stage research workflow:

• Gene Synthesis and Optimization: Design and synthesize the MAPgene sequence with optimal codon usage for Pichiapastoristo address the repetitive structure challenge.
• Recombinant Host Construction: Integrate the optimized MAPgene along with a suitable secretion leader sequence into the Pichiagenome for stable, high-level expression.
• Post-translational Modification System: Co-express the Tyrosinaseor Hydroxylaseenzyme responsible for the Tyrosineto DOPAconversion to ensure functional MAPproduction.
• Fermentation and Secretion Optimization: Develop high-cell-density fed-batch fermentation protocols to maximize cell growth and optimize induction conditions for high MAPsecretion titer.
• Product Characterization and Functionality: Quantify the final MAPyield and use assays e.g. HPLCto validate the DOPAcontent and confirm the functional adhesive activity.

Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.

Explore the potential for a cost-effective, high-quality MusselAdhesiveProteinsupply. CD Biosynsis provides customized strain and process engineering solutions:

• Detailed Functional MAP Titer and DOPA Content Reports g/L, DOPAcontent percentage.
• Consultation on downstream purification strategies tailored for highly charged, secreted proteins.
• Experimental reports include complete raw data on secretion efficiency, co-expressed enzyme activity, and protein stability.